
News|Articles|November 1, 2024
Culture Biosciences’ Mammalian Bioreactors: A Characterization Data Report
Author(s)Culture Biosciences
Culture Biosciences provides cloud-enabled 250mL bioreactors designed for various applications, including mammalian cell cultivation. Accurate transfer of process setpoints is critical to ensuring the success of moving client processes from other systems to Culture’s bioreactors. This whitepaper presents a detailed characterization study of Culture’s mammalian cell bioreactors, highlighting the precision and consistency achieved during process transfer.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5